Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Pfizer

Status: Completed

Conditions: Plaque Psoriasis

Study type: Observational

Funder types: Industry

Identifiers

NCT00227240

0881A-101789

Details and patient eligibility

About

The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.

Enrollment: 753 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Proven diagnosis of Plaque Psoriasis

Exclusion criteria

• Contraindications according to SmPC of Enbrel